Heterocyclic compounds, methods for the preparation thereof,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S334000, C546S256000, C546S257000

Reexamination Certificate

active

07994199

ABSTRACT:
The compounds of the present invention are of formula I:wherein A, R3, R4is as defined herein, are useful as ligands for nicotinic receptors.

REFERENCES:
patent: 5559124 (1996-09-01), Bencherif et al.
patent: 5602257 (1997-02-01), Zoltewicz et al.
patent: 5734059 (1998-03-01), Watanabe et al.
patent: 5741802 (1998-04-01), Kem et al.
patent: 5977144 (1999-11-01), Meyer et al.
patent: 2002/0028798 (2002-03-01), Demopulos et al.
patent: 2361437 (2000-08-01), None
patent: 196 22 353 (1997-12-01), None
patent: WO 92/15306 (1992-09-01), None
patent: WO 94 05288 (1994-03-01), None
patent: WO 98 03484 (1998-01-01), None
patent: WO 99 10338 (1999-03-01), None
patent: WO 01/73446 (2001-10-01), None
patent: WO 03 057140 (2003-07-01), None
W. R. Kem, “The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21)”, Behavioural Brain Research, Elsevier, vol. 113, No. 1/2, 2000, pp. 169-181.
C. De Fiebre, et al., “Characterization of a series of Anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative . . . ”,Molecular Pharm., vol. 47, No. 1, 1995, pp. 164-171.
Jeffrey D. Schmitt et al., “Chapter 5. Targeting Nicotinic Acetylcholine Receptors: Advances in Molecular Design and Therapies”Annual Reports in Medicinal Chemistry-35, pp. 41-51, 2000.
Mark W. Holladay et al., “Neuronal Nicotinic Acetylcholine Receptors as Targets for Drug Discovery”Journal of Medicinal Chemistery, 1997, vol. 40, No. 26, pp. 4169-4194.
Michael W. Decker et al., “Neuronal Nicotinic Acetylcholine Receptors: Novel Targets for CNS Therapeutics”Neuronal Nicotinic Acetylcholine Receptors: Novel Targets for CNS Therapeutics, 2000, pp. 1-14.
Dwight Flammia et al., “lobeline: Structure-Affinity Investigation of Nicotinic Acetylcholinergic Receptor Binding”J. Med. Chem. 1999, vol. 42, No. 18, pp. 3726-3731.
R. Azuma et al., “Metabolism and Disposition of GTS-21, a novel drug for Alzheimer's disease”Xenobiotica, 1999, vol. 29, No. 7, pp. 747-762.
Karen E. Stevens et al., “Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice”Psychopharmacology1998, No. 136, pp. 320-327.
Ryotaro Azuma et al., “The effect of repeat administration of GTS-21 on mixed-function oxidase activities in rat”,Toxicology Letters 110, 1999, pp. 137-144.
Alberici et al., Tet. Lett, 24(18) (1983), pp. 1937-1940.
De Kimpe, et al., Tet. Lett. 34(29) (1993), pp. 4693-4696.
Leete, J. org. Chem., 44(2), (1979), pp. 165-168.
Mundy et al., Synthetic Commun., 2(4), (1972), pp. 197-200.
Sultana et al., Biorganic & Medicinal Chemistry, 10 (2002), pp. 2963-2971.
Villemin et al., React. Kinet. Catal. Lett, 72(1), (2001), pp. 3-10.
Zoltewicz et al., Heterocycles, vol. 35, No. 1 (1993), pp. 171-180.
Zoltewicz et al., J. org. Chem., (1989), 54, pp. 4462-4468.
Zoltewicz et al., OPPI Briefs, 27, 4 (1995), pp. 510-513.
Thomson Innovation, English Translation of Claims and Description, Retrieved from Thomson Innovation Record View on Jun. 16, 2010; English Abstract of DE19622353.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic compounds, methods for the preparation thereof,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic compounds, methods for the preparation thereof,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds, methods for the preparation thereof,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2681622

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.